Tissue-Engineered Vascular Grafts for Hemodialysis Access.

Leon X Min1,2, Aurelie Tran3, Danielle L Montano4

  • 1School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.

Kidney360
|February 24, 2026
PubMed
Summary

Tissue-engineered vascular grafts (TEVGs) show promise for hemodialysis (HD) access when traditional methods fail. This review examines TEVGs in clinical trials, focusing on their characteristics and outcomes for patients needing HD.